Aratana Therapeutics Inc (NASDAQ:PETX)

13.57
Delayed Data
As of May 29
 -0.13 / -0.95%
Today’s Change
9.20
Today|||52-Week Range
20.63
-23.85%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close13.70
Today’s open13.63
Day’s range13.51 - 13.85
Volume159,212
Average volume (3 months)234,515
Market cap$478.3M
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)-233.33%
Earnings growth (this year)-15.67%
Earnings growth (next 5 years)+9.06%
Revenue growth (last year)+523.58%
P/E ratioNM
Price/Sales691.60
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...+0.70+6.67%
TBPHTheravance Biopharma...-0.38-2.65%
SCLNSciClone Pharmaceuti...-0.21-2.22%
VSARVersartis Inc-0.25-1.58%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$767.0K
Annual profit (last year)-$38.8M
Net profit margin-5,060.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Financial Officer &
Treasurer
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers